Discovery of DLL3-Targeting Macrocyclic Peptide Radioligand Therapy for the Treatment of SCLC
Fred Zecri Mariana Oncology a Novartis Company
This website uses cookies and similar technologies to understand visitor experiences. By using this website, you consent to UNC-Chapel Hill's cookie usage in accordance with their Privacy Notice.